跳至主要内容
临床试验/TCTR20221104004
TCTR20221104004尚未招募1 期

Clinical Efficacy and Safety of Warm Acupuncture in the treatment of Type 2 Diabetic Kidney Disease: A protocol of a randomized controlled trial

Hongbo Chen0 个研究点目标入组 84 人开始时间: 2022年11月4日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1 Meet the diagnostic criteria of type 2 DKD
  • 2 Age no less than 18 years old, and be not more than 70 years old, regardless of gender
  • 3With the 24-hour urinary protein quantification was 0.5-3.5 g
  • 4 With serum creatinine less than 265umol/L
  • 5 Patients voluntarily participated in the trial and signed informed consent

排除标准

  • (1) Nephropathy due to hypertension or other diseases;
  • (2) Complicated with severe complications and other serious organ dysfunction;
  • (3)Complicated with severe heart disease (NYHA class 3 or above, severe arrhythmia), abnormal liver function (alanine aminotransferase, aspartate aminotransferase no less than 1.5 times the upper limit of normal value), hematopoietic system diseases (moderate to severe anemia);
  • (4) Complicated with severe infection, diabetic ketoacidosis, hyperkalemia;
  • (5) Complicated with severe mental illness;
  • (6) Pregnant or lactating women;
  • (7) Patients with a history of allergy to one of the drugs used in the study;
  • (8) Subjects participating in clinical trials of other drugs.

研究者

发起方
Hongbo Chen

相似试验

Clinical Efficacy and Safety of Warm Acupuncture in... | 临床试验